Delivery Order SPE2DB25D3012-SPE2DB25FXAFV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,224.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Aprepitant 130mg/18ml (a chemotherapy-related nausea and vomiting preventative medication). This non-set-aside delivery order is expected to reach completion by September 8, 2025, with fulfillment taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $7,093.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567873449 - APREPITANT 40 MG CAPSULE UD 5S, and has a firm fixed price pricing type with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,377.56, is a delivery order for the supply of 4567772479 APREPITANT 40 MG CAPSULE UD 5S. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp, the prime contractor, has an extensive history of federal contract awards,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,785.12, is for the delivery of APREPITANT 125 MG CAPSULE UD 6S, a prescription medication. The contract is a firm fixed-price, indefinite delivery vehicle with a performance period through November 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen is the...
- The Defense Logistics Agency awarded a $2,249.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562199116 APREPITANT 40 MG CAPSULE UD 5S. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 18, 2023 in support of DLA programs. Amerisourcebergen will perform under the contract without a set-aside designation. No subcontractors or additional context were provided regarding DLA's use of the products.
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAFVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,758.31 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal procurement requirements through competitive awards across multiple therapeutic domains. Aprepitant, an anti-nausea medication commonly used in chemotherapy regimens, represents one of many specialized pharmaceutical products the company delivers under its DLA contracts, which support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/18/25 |